Latest Innovation News

RooLife Group has secured a $64 million two-year supply agreement to distribute its branded coffee and food products in China, reinforcing its expansion strategy in the fast-growing market.

Decidr AI Industries has successfully completed a $20 million placement, positioning itself to accelerate international growth and advance its AI technology platform.

The Environmental Group's subsidiary EGL Baltec has landed a $9.3 million contract to supply critical gas turbine exhaust systems for an 800MW power plant in the Dominican Republic, reinforcing its role in renewable energy support.

HeraMED is fast-tracking its AI-driven maternity care technologies, including an early release of its AI Clinician Assistant and predictive models for high-risk pregnancies, aiming to revolutionize digital women’s health globally.

Starpharma has entered a significant collaboration with Genentech to develop dendrimer-drug conjugates for oncology, securing an upfront payment and potential milestone earnings exceeding half a billion dollars.

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Locksley Resources reports robust metallurgical testwork from its Mojave Project, confirming high antimony recoveries and concentrate grades that support a domestic US supply chain. The results align with US strategic priorities for critical mineral independence.

Activeport Group Ltd has successfully raised $6.68 million through a two-tranche placement, positioning the company to accelerate its software development and target cash flow positivity in FY26.

EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.

JAYRIDE Group Limited has confirmed Randy Prado as CEO and Ram Navaratnam as Finance Director, cementing leadership as it advances its SaaS mobility platform with pilots in Southeast Asia.

Following its recent sale transaction, MPR Australia Limited announces significant board resignations alongside continued leadership under CEO Nathan Wise, signaling a strategic transition phase.